The problem of how to genetically modify cells in order to maximize a certain
cellular phenotype has taken center stage in drug development over the last few
years (with, for example, genetically edited CAR-T, CAR-NK, and CAR-NKT cells
entering cancer clinical trials). Exhausting the s